Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancerProspective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technologyAutomated DNA sequence-based early warning system for the detection of methicillin-resistant Staphylococcus aureus outbreaksThe primary transcriptome of the Escherichia coli O104:H4 pAA plasmid and novel insights into its virulence gene expression and regulationShiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndromeEnterohemorrhagic Escherichia coli hemolysin employs outer membrane vesicles to target mitochondria and cause endothelial and epithelial apoptosisSex and virulence in Escherichia coli: an evolutionary perspectiveVirulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain.Identification and distribution of the enterohemorrhagic Escherichia coli factor for adherence (efa1) gene in sorbitol-fermenting Escherichia coli O157: H-.Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: characterization and evolutionary considerationsShiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?Anaerobic conditions promote expression of Sfp fimbriae and adherence of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM to human intestinal epithelial cells.Matching IR-MALDI-o-TOF mass spectrometry with the TLC overlay binding assay and its clinical application for tracing tumor-associated glycosphingolipids in hepatocellular and pancreatic cancer.Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndromeSaliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk.Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease.Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany.Distribution of the urease gene cluster among and urease activities of enterohemorrhagic Escherichia coli O157 isolates from humansEnterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen.Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium.Enterohaemorrhagic Escherichia coli in human medicine.Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM.New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome.Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity.Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111.Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium.Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activityEnterohaemorrhagic Escherichia coli O26:H11/H-: a human pathogen in emergence.Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli.Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.Phylogeny and disease association of Shiga toxin-producing Escherichia coli O91.Epidemiology and pathogenesis of enterohaemorrhagic Escherichia coil.EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5.Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.
P50
Q21090050-D9384C81-E704-4755-A3C2-91039BE52F6FQ21091008-A7E0910A-88AB-42BA-8BA2-9D0575F8B811Q25255772-F456EE55-5152-444D-AC1B-77BF3D550DCBQ27977592-AE998526-5DE6-4C3C-900C-3E2784BC00FEQ28243693-29C2563E-E671-4B16-9B53-E9ACC7243A39Q28537654-C8D46115-C3FB-4281-BB22-75059B374BA1Q28768050-68DC72AC-188E-4A54-BC02-0CD457ABD54EQ30661555-0B495A0A-B4ED-411B-8F41-5905460F201CQ30867242-32BC9450-AD41-4792-AC21-405DC6BE3ABFQ30936118-9EC1A8A4-5DE3-469A-8D23-AAC5A9F6371DQ33302118-ED173A11-71FE-4EA6-B1E5-61BDFC86470CQ33310576-A2848E47-0508-4B15-A9CE-92BBBFB93DA3Q33320050-6C02EBDD-05B1-442E-BDE1-007DF76241A0Q33340303-26D2009F-5747-4584-B9F6-957747522FB9Q33342197-06D7BA5D-BCB3-4D73-B276-1EDB7CD642A4Q33343456-F82F323C-56BC-429C-A60A-1B2E6BA9AFADQ33343898-DEF62C8A-F594-464A-8DCB-A19CFF0A76DFQ33347453-1C4E7D90-9C2E-4779-BD2C-6881F78B29CBQ33347774-D4236744-6141-4562-AB0D-C1726A1B0E95Q33348352-7DA9F472-B7ED-4D54-9432-BC9DCE2E965AQ33359875-BD8F4F00-317D-4F0A-8A2C-87ACCDB6BDD5Q33364864-B8193F53-F3F9-4E63-BDEC-FF9BAF9DF324Q33367966-8A7A0F28-ACFE-4B18-B8E1-8F48AA94667FQ33368023-D5EC7A5F-2EC2-468A-9F15-2029330F17E8Q33368999-E4A545BF-CCF0-4270-ADC3-3EAAEFCCDB25Q33370432-F854FB68-E607-410D-978C-A6945FADBC86Q33370725-85EDD75A-11D1-4D46-BA06-DA43A0727BEFQ33370727-4411302A-25D4-4EF9-AC2C-64194F33EF0CQ33371092-013F4AF1-F44A-4211-8C1F-DA6482F7DA47Q33373527-1887608D-A6AD-43B6-8DFC-737F8B3E0983Q33374322-6FE91E15-2A8A-4B03-8AAA-F49A7A145E6AQ33375505-60D2CB4C-2B0C-4808-B8B6-E4320B9CF8EAQ33376279-FA8307F0-F5FF-4CE1-ABA2-88634598EBBDQ33376329-4EDBF70A-B4E0-4246-886E-4090B71E3735Q33376329-C1E03681-B83F-45B6-A355-45FE507B90ECQ33380625-45B5FAAE-79BB-415D-8096-4AC6BB02BC09Q33383102-208DC99B-E72C-4BBF-93B5-620296AA76C1Q33386431-77F86774-0234-40FF-94BC-E212E01DE212Q33387443-40A5F459-C066-4DD3-8DF4-532674F54D87Q33387443-F558E0DB-5012-4B81-8FC2-E3EE0DD2A7BA
P50
description
Duits hoogleraar
@nl
German university teacher
@en
German university teacher
@en-ca
German university teacher
@en-gb
Saksamaa ülikooli õppejõud
@et
deutscher Mikrobiologe
@de
léachtóir ollscoile Gearmánach
@ga
profesor universitar german
@ro
profesor universitar gjerman
@sq
profesor universitario alemán
@es
name
Helge Karch
@ast
Helge Karch
@ca
Helge Karch
@da
Helge Karch
@de
Helge Karch
@en
Helge Karch
@es
Helge Karch
@fr
Helge Karch
@nb
Helge Karch
@nds
Helge Karch
@nl
type
label
Helge Karch
@ast
Helge Karch
@ca
Helge Karch
@da
Helge Karch
@de
Helge Karch
@en
Helge Karch
@es
Helge Karch
@fr
Helge Karch
@nb
Helge Karch
@nds
Helge Karch
@nl
prefLabel
Helge Karch
@ast
Helge Karch
@ca
Helge Karch
@da
Helge Karch
@de
Helge Karch
@en
Helge Karch
@es
Helge Karch
@fr
Helge Karch
@nb
Helge Karch
@nds
Helge Karch
@nl
P106
P1412
P1559
Helge Karch
@de
P19
P21
P31
P569
1953-07-06T00:00:00Z